<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>The Longevity Buffet  - Hex Index</title>
  <link rel="stylesheet" href="../../styles.css">
</head>
<body class="reading-mode">
  <header class="reading-header">
    <a href="../../index.html" class="back-link">&larr; Back to Library</a>
  </header>
  <main class="reading-content">
    
    <article class="article-page">
      <header class="article-header">
        <h1>The Longevity Buffet </h1>
        <div class="article-meta">
          <span class="author">By Various</span>
          <span class="separator">&middot;</span>
          <a href="../../publication/londonlongevity/index.html" class="publication">
            London Longevity Newsletter
          </a>
          <span class="separator">&middot;</span><time>May 2, 2025</time>
          <span class="separator">&middot;</span>
          <span class="read-time">2 min read</span>
        </div>
      </header>

      

      <div class="article-excerpt">
        <div><hr></div><p>Welcome to first issue of the Longevity Buffet newsletter by London Longevity! </p><p>We‚Äôre excited to introduce a new curated newsletter to bring our community together, and shine the spotlight on things and people we find most fascinating in the world of longevity science and business. </p><p>Starting off short and sweet, with assorted links and bi-weekly updates, but the format will evolve as we go. SUGGESTIONS WELCOME! </p><p>Here goes! </p><p><strong>RESEARCH SPOTLIGHT </strong>üß¨ </p><p>Gene Editing and Aging: A Bibliometric Analysis of Global Trends and Frontier Themes (2015-2024) - <a href="https://www.nature.com/articles/s43587-025-00830-4">Read More</a>  </p><p>Drug repurposing studies in worms identified a new candidate for Alzheimer's, fluphenazine - <a href="https://www.biorxiv.org/content/10.1101/2025.04.24.650484v2">Read More</a></p><p>On the causal connection in lifespan correlations and the possible existence of a ‚Äònumber of life‚Äô at molecular level - <a href="https://www.nature.com/articles/s41598-024-82671-6">Read More</a> </p><p><strong>MARKET MOMENTUM</strong> üí∏ </p><p>Ex-Calico scientist launches Stately Bio with new way to study cells, raises 12mil - <a href="https://endpts.com/exclusive-ai-biotech-stately-bio-raises-12m-for-cell-imaging/">Read More</a></p><p>Biolinq lands $100m to bring wearable metabolic biosensor to market - <a href="https://longevity.technology/news/biolinq-lands-100m-to-bring-wearable-metabolic-biosensor-to-market/">Read More</a> </p><p>Indicative of the growing trend of Hospitality x Health or social wellness, Seveno Capital Launches With US$70m Fund in Japan - <a href="https://www.businesswire.com/news/home/20250415590582/en/Seveno-Capital-Launches-With-US%2470m-Commitment-by-Human-Healthspan-Entrepreneur-Allen-Law-and-Makes-Inaugural-Investment-in-A-Cabin-Company">Read More</a>  </p><p><strong>COOL NEW TOOL </strong>üî®   </p><p><a href="https://www.linkedin.com/feed/update/urn:li:activity:7323730410562023425/">FutureHouse Platform</a> just launched some <a href="https://platform.futurehouse.org/login">AI Agents for Scientific Research</a> - A general-purpose agent (Crow); An agent to automate literature reviews (Falcon); and An agent to answer the question ‚ÄúHas anyone done X before‚Äù (Owl).</p><p><a href="https://www.convergentresearch.org/">Convergent Research</a> launched a new web portal, <strong><a href="http://gap-map.org">gap-map.org</a>,</strong> to ‚Äúexplore the landscape of R&amp;D gaps holding back science and the bridge-scale <a href="https://www.essentialtechnology.blog/p/introducing-the-convergent-research">fundamental development</a> efforts that might allow humanity to solve them‚Äù. These bottlenecks, if addressed ambitiously, have the potential to accelerate the pace of innovation astronomically. </p><p><strong>ALPHA</strong> (the edge of having unique insights *earlier* than others/the market to drive asymmetric returns) üëÄ </p><p>One Word (alright, three) - <a href="https://www.linkedin.com/posts/elliot-hershberg_on-biotech-quant-firms-one-alternative-activity-7310737312051515392-DJOa?utm_source=share&amp;utm_medium=member_desktop&amp;rcm=ACoAAC4iqYgB-FxXiHJUyal9e-DyTiNm_j0OGB0">Biology Quant Firms </a> </p><p>(See also - <a href="https://centuryofbio.com/p/commoditization">On Modality Commoditisation</a>)</p><p><strong>COMMUNITY SPOTLIGHT</strong> ü•≥ </p><p>A member of our community just launched a new dedicated Jobs Board for the longevity sector ‚Äî <a href="http://longevityjobs.org">longevityjobs.org</a>  ‚Äî check it out if you‚Äôre looking to hire or get hired! </p><p><strong>That's a wrap for Issue 01!</strong></p><p>See you again in a couple weeks,</p><p><em>Prasasya from London Longevity  </em></p><p>Share your thoughts by replying to this email or joining our community on <a href="https://chat.whatsapp.com/Keypu9H5AaY8R4T2jHtyi9">WhatsApp</a> and <a href="https://www.linkedin.com/company/london-longevity/?viewAsMember=true">LinkedIn</a>.</p><p>Visit <a href="https://londonlongevity.net/">londonlongevity.net</a> for upcoming announcements.</p>
      </div>

      <div class="read-full-article">
        <a href="https://londonlongevity.substack.com/p/the-longevity-buffet" class="read-button" target="_blank" rel="noopener">
          Read full article on London Longevity Newsletter &rarr;
        </a>
        <p class="copyright-note">
          This excerpt is provided for preview purposes.
          Full article content is available on the original publication.
        </p>
      </div>
    </article>
  
  </main>
</body>
</html>